speb/financial-data huggingface dataset:
INMD balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 2154000.00
INMD balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 2154000.00
INMD cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -285385000.00
INMD income_statement (annual, 2024-12-31) — Net Income: 181275000.00
INMD income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 181275000.00
INMD income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 181275000.00
INMD income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 181275000.00
INMD income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 181275000.00
INMD cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 181275000.00
INMD income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 181275000.00
INMD income_statement (annual, 2024-12-31) — Net Interest Income: 30938000.00
INMD cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 162875000.00
INMD income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 30938000.00
INMD balance_sheet (annual, 2024-12-31) — Net PPE: 11054000.00
INMD cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -669000.00
INMD balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 703813000.00
INMD balance_sheet (annual, 2024-12-31) — Non Current Accounts Receivable: 3176000.00
INMD balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 56285000.00
INMD balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 3336000.00
INMD balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 3336000.00
INMD balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 56285000.00
INMD income_statement (annual, 2024-12-31) — Normalized EBITDA: 113259000.00
INMD income_statement (annual, 2024-12-31) — Normalized Income: 181275000.00
INMD cash_flow (annual, 2024-12-31) — Operating Cash Flow: 132664000.00
INMD cash_flow (annual, 2024-12-31) — Operating Gains Losses: 167000.00
INMD cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -3000.00
INMD income_statement (annual, 2024-12-31) — Operating Income: 112531000.00
INMD income_statement (annual, 2024-12-31) — Operating Revenue: 394818000.00
INMD balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 69558670.00
INMD balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 16044000.00
INMD income_statement (annual, 2024-12-31) — Other Gand A: 10032000.00
INMD cash_flow (annual, 2024-12-31) — Other Non Cash Items: -4401000.00
INMD balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 3356000.00
INMD balance_sheet (annual, 2024-12-31) — Other Properties: 11752000.00
INMD balance_sheet (annual, 2024-12-31) — Other Receivables: 3293000.00
INMD balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 441143000.00
INMD balance_sheet (annual, 2024-12-31) — Payables: 14715000.00
INMD balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 17094000.00
INMD balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 16725000.00
INMD balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 16725000.00
INMD balance_sheet (annual, 2024-12-31) — Prepaid Assets: 17381000.00
INMD balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 17381000.00
INMD income_statement (annual, 2024-12-31) — Pretax Income: 143469000.00
INMD cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 2614000.00
INMD balance_sheet (annual, 2024-12-31) — Properties: 0.00
INMD balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
INMD cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 572000.00
INMD cash_flow (annual, 2024-12-31) — Purchase Of Investment: -504408000.00
INMD cash_flow (annual, 2024-12-31) — Purchase Of PPE: -669000.00
INMD balance_sheet (annual, 2024-12-31) — Raw Materials: 15454000.00
INMD balance_sheet (quarterly, 2024-12-31) — Raw Materials: 15454000.00
INMD balance_sheet (annual, 2024-12-31) — Receivables: 41051000.00
INMD income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 77752000.00
INMD income_statement (annual, 2024-12-31) — Reconciled Depreciation: 728000.00
INMD cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -285385000.00
INMD income_statement (annual, 2024-12-31) — Research And Development: 13137000.00
INMD balance_sheet (annual, 2024-12-31) — Retained Earnings: 874701000.00
INMD balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 874701000.00
INMD cash_flow (annual, 2024-12-31) — Sale Of Investment: 667283000.00
INMD income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 181366000.00
INMD income_statement (annual, 2024-12-31) — Selling General And Administration: 191398000.00
INMD balance_sheet (annual, 2024-12-31) — Share Issued: 87583673.00
INMD cash_flow (annual, 2024-12-31) — Stock Based Compensation: 16569000.00
INMD balance_sheet (annual, 2024-12-31) — Stockholders Equity: 703813000.00
INMD balance_sheet (annual, 2024-12-31) — Tangible Book Value: 703813000.00
INMD income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
INMD income_statement (annual, 2024-12-31) — Tax Provision: -37806000.00
INMD income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
INMD balance_sheet (annual, 2024-12-31) — Taxes Receivable: 1423000.00
INMD balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 1423000.00
INMD balance_sheet (annual, 2024-12-31) — Total Assets: 785667000.00
INMD balance_sheet (annual, 2024-12-31) — Total Capitalization: 703813000.00
INMD balance_sheet (annual, 2024-12-31) — Total Debt: 7822000.00
INMD balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 703813000.00
INMD income_statement (annual, 2024-12-31) — Total Expenses: 282287000.00
INMD balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 81854000.00
INMD balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 71215000.00
INMD balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 12003000.00
INMD income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 112531000.00
INMD balance_sheet (annual, 2024-12-31) — Total Tax Payable: 933000.00
INMD balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 933000.00
INMD balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 18025003.00
INMD balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 18025003.00
INMD balance_sheet (annual, 2024-12-31) — Treasury Stock: 367825000.00
INMD balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 367825000.00
INMD balance_sheet (annual, 2024-12-31) — Working Capital: 644601000.00
INMD income_statement (quarterly, 2025-03-31) — +Operating Expense: 45293000.00
INMD income_statement (quarterly, 2025-03-31) — +Total Revenue: 77874000.00
INMD balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 15052000.00
INMD balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 32367000.00
INMD income_statement (quarterly, 2025-03-31) — Basic Average Shares: 68760000.00
INMD income_statement (quarterly, 2025-03-31) — Basic EPS: 0.26
INMD cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 155329000.00
INMD cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -85000.00
INMD balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 5588000.00
INMD balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 145948000.00
INMD balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 512925000.00
INMD cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -99466000.00
INMD cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 75485000.00
INMD cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 14044000.00
INMD cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 1270000.00
INMD cash_flow (quarterly, 2025-03-31) — Change In Inventory: -4233000.00
INMD cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -3287000.00
INMD cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -837000.00
INMD cash_flow (quarterly, 2025-03-31) — Change In Payable: 1270000.00
INMD cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 1270000.00
INMD cash_flow (quarterly, 2025-03-31) — Change In Receivables: 1012000.00
INMD cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -6075000.00
INMD cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 4544000.00
INMD cash_flow (quarterly, 2025-03-31) — Changes In Cash: -9937000.00
INMD balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 619428000.00
INMD cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -99960000.00
INMD income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 16963000.00
INMD balance_sheet (quarterly, 2025-03-31) — Current Assets: 634637000.00
INMD balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 15861000.00
INMD balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 15861000.00
INMD balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 72658000.00
INMD cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 896000.00
INMD cash_flow (quarterly, 2025-03-31) — Deferred Tax: 896000.00
INMD cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 174000.00
INMD cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 174000.00
INMD income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 69435000.00
INMD income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.26
INMD income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 18201000.00
INMD income_statement (quarterly, 2025-03-31) — EBIT: 15618000.00
INMD income_statement (quarterly, 2025-03-31) — EBITDA: 15792000.00
INMD cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 556000.00
INMD cash_flow (quarterly, 2025-03-31) — End Cash Position: 145948000.00
INMD cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -99466000.00
INMD cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 13959000.00
INMD cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -2000.00
INMD income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 2671000.00
INMD balance_sheet (quarterly, 2025-03-31) — Gross PPE: 11366000.00
INMD income_statement (quarterly, 2025-03-31) — Gross Profit: 60911000.00
INMD income_statement (quarterly, 2025-03-31) — Interest Income: 6859000.00
INMD income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 6859000.00
INMD balance_sheet (quarterly, 2025-03-31) — Inventory: 63781000.00
INMD cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 75485000.00
INMD balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 700000.00
INMD balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 5588000.00
INMD balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 5588000.00
INMD cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -99960000.00
INMD income_statement (quarterly, 2025-03-31) — Net Income: 18201000.00
INMD income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 18201000.00
INMD income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 18201000.00
INMD income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 18201000.00
INMD income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 18201000.00
INMD cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 18201000.00
INMD income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 18201000.00
INMD income_statement (quarterly, 2025-03-31) — Net Interest Income: 6859000.00
INMD cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 75570000.00
INMD income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 6859000.00
INMD balance_sheet (quarterly, 2025-03-31) — Net PPE: 11366000.00
INMD cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -85000.00
INMD balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 619428000.00
INMD balance_sheet (quarterly, 2025-03-31) — Non Current Accounts Receivable: 2694000.00
INMD balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 55338000.00
INMD balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 3393000.00
INMD balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 3393000.00
INMD balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 55338000.00
INMD income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 15792000.00
INMD income_statement (quarterly, 2025-03-31) — Normalized Income: 18201000.00
INMD cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 14044000.00
INMD cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -2000.00
INMD income_statement (quarterly, 2025-03-31) — Operating Income: 15618000.00
INMD income_statement (quarterly, 2025-03-31) — Operating Revenue: 77874000.00
INMD balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 60918785.00
INMD balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 41745000.00
INMD income_statement (quarterly, 2025-03-31) — Other Gand A: 2671000.00
INMD balance_sheet (quarterly, 2025-03-31) — Other Investments: 700000.00
INMD cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -1574000.00
INMD balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 3668000.00
INMD balance_sheet (quarterly, 2025-03-31) — Other Properties: 11366000.00
INMD balance_sheet (quarterly, 2025-03-31) — Other Receivables: 25564000.00
INMD balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 366977000.00
INMD balance_sheet (quarterly, 2025-03-31) — Payables: 15052000.00
INMD balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 15052000.00
INMD income_statement (quarterly, 2025-03-31) — Pretax Income: 22477000.00
INMD cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 494000.00
INMD cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: -94000.00
INMD cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -20877000.00
INMD cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -85000.00
INMD balance_sheet (quarterly, 2025-03-31) — Receivables: 57931000.00
INMD income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 16963000.00
INMD income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 174000.00
INMD cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -99960000.00
INMD income_statement (quarterly, 2025-03-31) — Research And Development: 2895000.00
INMD cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 96447000.00
INMD income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 39727000.00
INMD income_statement (quarterly, 2025-03-31) — Selling General And Administration: 42398000.00
INMD balance_sheet (quarterly, 2025-03-31) — Share Issued: 85893788.00
INMD cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2518000.00
INMD balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 619428000.00
INMD balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 619428000.00
INMD income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
INMD income_statement (quarterly, 2025-03-31) — Tax Provision: 4276000.00
INMD income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.19
INMD balance_sheet (quarterly, 2025-03-31) — Total Assets: 704735000.00
INMD balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 619428000.00
INMD balance_sheet (quarterly, 2025-03-31) — Total Debt: 5588000.00
INMD balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 619428000.00
INMD income_statement (quarterly, 2025-03-31) — Total Expenses: 62256000.00
INMD balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 85307000.00
INMD balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 70098000.00
INMD balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 12649000.00
INMD income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 15618000.00
INMD balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 24975003.00
INMD balance_sheet (quarterly, 2025-03-31) — Working Capital: 561979000.00
INMD income_statement (quarterly, 2025-06-30) — +Operating Expense: 53569000.00
INMD income_statement (quarterly, 2025-06-30) — +Total Revenue: 95602000.00
INMD balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 17482000.00
INMD balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 35654000.00
INMD income_statement (quarterly, 2025-06-30) — Basic Average Shares: 63252000.00
INMD income_statement (quarterly, 2025-06-30) — Basic EPS: 0.42
INMD cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 145948000.00
INMD cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -219000.00
INMD balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 6103000.00
INMD balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 216237000.00
INMD balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 510683000.00
INMD cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -26979000.00
INMD cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 71656000.00
INMD cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 24072000.00
INMD cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 2430000.00
INMD cash_flow (quarterly, 2025-06-30) — Change In Inventory: -4329000.00
INMD cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 127000.00
INMD cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -2903000.00
INMD cash_flow (quarterly, 2025-06-30) — Change In Payable: 2430000.00
INMD cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 2430000.00
INMD cash_flow (quarterly, 2025-06-30) — Change In Receivables: -2009000.00
INMD cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -6684000.00
INMD cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -3285000.00
INMD cash_flow (quarterly, 2025-06-30) — Changes In Cash: 68749000.00
INMD balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 628437000.00
INMD cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -27484000.00
INMD income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 19152000.00
INMD balance_sheet (quarterly, 2025-06-30) — Current Assets: 638781000.00
INMD balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 12996000.00
INMD balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 12996000.00
INMD balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 66534000.00
INMD cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 566000.00
INMD cash_flow (quarterly, 2025-06-30) — Deferred Tax: 566000.00
INMD cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 191000.00
INMD cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 191000.00
INMD income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 63637000.00
INMD income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.42
INMD income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 26742000.00
INMD income_statement (quarterly, 2025-06-30) — EBIT: 22881000.00
INMD income_statement (quarterly, 2025-06-30) — EBITDA: 23072000.00
INMD cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 1540000.00
INMD cash_flow (quarterly, 2025-06-30) — End Cash Position: 216237000.00
INMD cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -26979000.00
INMD cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 23853000.00
INMD cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 5000.00
INMD income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 2723000.00
INMD balance_sheet (quarterly, 2025-06-30) — Gross PPE: 11559000.00
INMD income_statement (quarterly, 2025-06-30) — Gross Profit: 76450000.00
INMD balance_sheet (quarterly, 2025-06-30) — Inventory: 68110000.00
INMD cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 71656000.00
INMD balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 700000.00
INMD balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 6103000.00
INMD balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 6103000.00
INMD cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -27484000.00
INMD income_statement (quarterly, 2025-06-30) — Net Income: 26742000.00
INMD income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 26742000.00
INMD income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 26742000.00
INMD income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 26742000.00
INMD income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 26742000.00
INMD cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 26742000.00
INMD income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 26742000.00
INMD income_statement (quarterly, 2025-06-30) — Net Interest Income: 8062000.00
INMD cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 71875000.00
INMD income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 8062000.00
INMD balance_sheet (quarterly, 2025-06-30) — Net PPE: 11559000.00
INMD cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -219000.00
INMD balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 628437000.00
INMD balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 2545000.00
INMD balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 54763000.00
INMD balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 3355000.00
INMD balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 3355000.00
INMD balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 54763000.00
INMD income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 23072000.00
INMD income_statement (quarterly, 2025-06-30) — Normalized Income: 26742000.00
INMD cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 24072000.00
INMD cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 5000.00
INMD income_statement (quarterly, 2025-06-30) — Operating Income: 22881000.00
INMD income_statement (quarterly, 2025-06-30) — Operating Revenue: 95602000.00
INMD balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 63209152.00
INMD balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 36056000.00
INMD income_statement (quarterly, 2025-06-30) — Other Gand A: 2723000.00
INMD balance_sheet (quarterly, 2025-06-30) — Other Investments: 700000.00
INMD cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -313000.00
INMD balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 3919000.00
INMD balance_sheet (quarterly, 2025-06-30) — Other Properties: 11559000.00
INMD balance_sheet (quarterly, 2025-06-30) — Other Receivables: 24334000.00
INMD balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 294446000.00
INMD balance_sheet (quarterly, 2025-06-30) — Payables: 17482000.00
INMD balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 17482000.00
INMD income_statement (quarterly, 2025-06-30) — Pretax Income: 30943000.00
INMD cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 505000.00
INMD cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 147000.00
INMD cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -25000000.00
INMD cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -219000.00
INMD balance_sheet (quarterly, 2025-06-30) — Receivables: 59988000.00
INMD income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 19152000.00
INMD income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 191000.00
INMD cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -27484000.00
INMD income_statement (quarterly, 2025-06-30) — Research And Development: 3372000.00
INMD cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 96875000.00
INMD income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 47474000.00
INMD income_statement (quarterly, 2025-06-30) — Selling General And Administration: 50197000.00
INMD balance_sheet (quarterly, 2025-06-30) — Share Issued: 63209152.00
INMD cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 3418000.00
INMD balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 628437000.00
INMD balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 628437000.00
INMD income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
INMD income_statement (quarterly, 2025-06-30) — Tax Provision: 4201000.00
INMD income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.14
INMD balance_sheet (quarterly, 2025-06-30) — Total Assets: 708348000.00
INMD balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 628437000.00
INMD balance_sheet (quarterly, 2025-06-30) — Total Debt: 6103000.00
INMD balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 628437000.00
INMD income_statement (quarterly, 2025-06-30) — Total Expenses: 72721000.00
INMD balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 79911000.00
INMD balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 69567000.00
INMD balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 13377000.00
INMD income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 22881000.00
INMD income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: -8062000.00
INMD balance_sheet (quarterly, 2025-06-30) — Working Capital: 572247000.00
INMD income_statement (quarterly, 2025-09-30) — +Operating Expense: 51412000.00
INMD income_statement (quarterly, 2025-09-30) — +Total Revenue: 93165000.00
INMD balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 16723000.00
INMD balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 38095000.00
INMD income_statement (quarterly, 2025-09-30) — Basic Average Shares: 63291000.00
INMD income_statement (quarterly, 2025-09-30) — Basic EPS: 0.35
INMD cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 216237000.00
INMD cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -134000.00
INMD balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 5593000.00
INMD balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 252437000.00
INMD balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 532308000.00
INMD cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 249000.00
INMD cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 11668000.00
INMD cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 24467000.00
INMD cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -759000.00
INMD cash_flow (quarterly, 2025-09-30) — Change In Inventory: -3293000.00
INMD cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 564000.00
INMD cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 1874000.00
INMD cash_flow (quarterly, 2025-09-30) — Change In Payable: -759000.00
INMD cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -759000.00
INMD cash_flow (quarterly, 2025-09-30) — Change In Receivables: -2500000.00
INMD cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -4114000.00
INMD cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -2353000.00
INMD cash_flow (quarterly, 2025-09-30) — Changes In Cash: 36384000.00
INMD balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 653385000.00
INMD cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
INMD income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 20856000.00
INMD balance_sheet (quarterly, 2025-09-30) — Current Assets: 666291000.00
INMD balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 15099000.00
INMD balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 15099000.00
INMD balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 68330000.00
INMD cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 602000.00
INMD cash_flow (quarterly, 2025-09-30) — Deferred Tax: 602000.00
INMD cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 156000.00
INMD cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 156000.00
INMD income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 63868000.00
INMD income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.34
INMD income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 21863000.00
INMD income_statement (quarterly, 2025-09-30) — EBIT: 20897000.00
INMD income_statement (quarterly, 2025-09-30) — EBITDA: 21053000.00
INMD cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -184000.00
INMD cash_flow (quarterly, 2025-09-30) — End Cash Position: 252437000.00
INMD cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 249000.00
INMD cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 24333000.00
INMD cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 11000.00
INMD income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 2899000.00
INMD balance_sheet (quarterly, 2025-09-30) — Gross PPE: 11160000.00
INMD income_statement (quarterly, 2025-09-30) — Gross Profit: 72309000.00
INMD balance_sheet (quarterly, 2025-09-30) — Inventory: 71403000.00
INMD cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 11668000.00
INMD balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 700000.00
INMD balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 5593000.00
INMD balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 5593000.00
INMD cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
INMD income_statement (quarterly, 2025-09-30) — Net Income: 21863000.00
INMD income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 21863000.00
INMD income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 21863000.00
INMD income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 21863000.00
INMD income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 21863000.00
INMD cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 21863000.00
INMD income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 21863000.00
INMD income_statement (quarterly, 2025-09-30) — Net Interest Income: 4721000.00
INMD cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 11802000.00
INMD income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 4721000.00
INMD balance_sheet (quarterly, 2025-09-30) — Net PPE: 11160000.00
INMD cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -134000.00
INMD balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 653385000.00
INMD balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 2350000.00
INMD balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 54104000.00
INMD balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 3126000.00
INMD balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 3126000.00
INMD balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 54104000.00
INMD income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 21053000.00
INMD income_statement (quarterly, 2025-09-30) — Normalized Income: 21863000.00
INMD cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 24467000.00
INMD cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 11000.00
INMD income_statement (quarterly, 2025-09-30) — Operating Income: 20897000.00
INMD income_statement (quarterly, 2025-09-30) — Operating Revenue: 93165000.00
INMD balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 63358750.00
INMD balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 36508000.00
INMD income_statement (quarterly, 2025-09-30) — Other Gand A: 2899000.00
INMD balance_sheet (quarterly, 2025-09-30) — Other Investments: 700000.00
INMD cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 3147000.00
INMD balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 4171000.00
INMD balance_sheet (quarterly, 2025-09-30) — Other Properties: 11160000.00
INMD balance_sheet (quarterly, 2025-09-30) — Other Receivables: 24485000.00
INMD balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 279871000.00
INMD balance_sheet (quarterly, 2025-09-30) — Payables: 16723000.00
INMD balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 16723000.00
INMD income_statement (quarterly, 2025-09-30) — Pretax Income: 25618000.00
INMD cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 249000.00
INMD cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 106000.00
INMD cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -153904000.00
INMD cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -134000.00
INMD balance_sheet (quarterly, 2025-09-30) — Receivables: 62580000.00
INMD income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 20856000.00
INMD income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 156000.00
INMD cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
INMD income_statement (quarterly, 2025-09-30) — Research And Development: 3543000.00
INMD cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 165706000.00
INMD income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 44970000.00
INMD income_statement (quarterly, 2025-09-30) — Selling General And Administration: 47869000.00
INMD balance_sheet (quarterly, 2025-09-30) — Share Issued: 63358750.00
INMD cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 2696000.00
INMD balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 653385000.00
INMD balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 653385000.00
INMD income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
INMD income_statement (quarterly, 2025-09-30) — Tax Provision: 3755000.00
INMD income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.15
INMD balance_sheet (quarterly, 2025-09-30) — Total Assets: 734605000.00
INMD balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 653385000.00
INMD balance_sheet (quarterly, 2025-09-30) — Total Debt: 5593000.00
INMD balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 653385000.00
INMD income_statement (quarterly, 2025-09-30) — Total Expenses: 72268000.00
INMD balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 81220000.00
INMD balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 68314000.00
INMD balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 12890000.00
INMD income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 20897000.00
INMD income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: -4721000.00
INMD balance_sheet (quarterly, 2025-09-30) — Working Capital: 597961000.00
INMD income_statement (annual, 2025-12-31) — +Operating Expense: 205583000.00
INMD income_statement (quarterly, 2025-12-31) — +Operating Expense: 55309000.00
INMD income_statement (annual, 2025-12-31) — +Total Revenue: 370495000.00
INMD income_statement (quarterly, 2025-12-31) — +Total Revenue: 103854000.00
INMD balance_sheet (annual, 2025-12-31) — Accounts Payable: 17912000.00
INMD balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 17912000.00
INMD balance_sheet (annual, 2025-12-31) — Accounts Receivable: 43504000.00
INMD balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 43504000.00
INMD balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -4880000.00
INMD balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -4880000.00
INMD balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 209615000.00
INMD balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 209615000.00
INMD balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -2371000.00
INMD balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -2371000.00
INMD income_statement (annual, 2025-12-31) — Basic Average Shares: 64633000.00
INMD income_statement (quarterly, 2025-12-31) — Basic Average Shares: 63335000.00
INMD income_statement (annual, 2025-12-31) — Basic EPS: 1.45
INMD income_statement (quarterly, 2025-12-31) — Basic EPS: 0.43
INMD cash_flow (annual, 2025-12-31) — Beginning Cash Position: 155329000.00
INMD cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 252437000.00
INMD cash_flow (annual, 2025-12-31) — Capital Expenditure: -972000.00
INMD cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -534000.00
INMD balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 8227000.00
INMD balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 8227000.00
INMD balance_sheet (annual, 2025-12-31) — Capital Stock: 251000.00
INMD balance_sheet (quarterly, 2025-12-31) — Capital Stock: 251000.00
INMD balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 302543000.00
INMD balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 302543000.00
INMD balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 555334000.00
INMD balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 555334000.00
INMD cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -126059000.00
INMD cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 137000.00
INMD cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 186032000.00
INMD cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 27223000.00
INMD cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 85257000.00
INMD cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 22674000.00
INMD cash_flow (annual, 2025-12-31) — Change In Account Payable: 4129000.00
INMD cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 1188000.00
INMD cash_flow (annual, 2025-12-31) — Change In Inventory: -14502000.00
INMD cash_flow (quarterly, 2025-12-31) — Change In Inventory: -2647000.00
INMD cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 2163000.00
INMD cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 4759000.00
INMD cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -4955000.00
INMD cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -3089000.00
INMD cash_flow (annual, 2025-12-31) — Change In Payable: 4129000.00
INMD cash_flow (quarterly, 2025-12-31) — Change In Payable: 1188000.00
INMD cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 4129000.00
INMD cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 1188000.00
INMD cash_flow (annual, 2025-12-31) — Change In Receivables: -11130000.00
INMD cash_flow (quarterly, 2025-12-31) — Change In Receivables: -7633000.00
INMD cash_flow (annual, 2025-12-31) — Change In Working Capital: -24295000.00
INMD cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -7422000.00
INMD cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -7452000.00
INMD cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -6358000.00
INMD cash_flow (annual, 2025-12-31) — Changes In Cash: 145230000.00
INMD cash_flow (quarterly, 2025-12-31) — Changes In Cash: 50034000.00
INMD balance_sheet (annual, 2025-12-31) — Common Stock: 251000.00
INMD balance_sheet (quarterly, 2025-12-31) — Common Stock: 251000.00
INMD balance_sheet (annual, 2025-12-31) — Common Stock Equity: 683198000.00
INMD balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 683198000.00
INMD cash_flow (annual, 2025-12-31) — Common Stock Payments: -127444000.00
INMD cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
INMD income_statement (annual, 2025-12-31) — Cost Of Revenue: 79525000.00
INMD income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 22554000.00
INMD balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 1710000.00
INMD balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 1710000.00
INMD balance_sheet (annual, 2025-12-31) — Current Assets: 698621000.00
INMD balance_sheet (quarterly, 2025-12-31) — Current Assets: 698621000.00
INMD balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 3219000.00
INMD balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 3219000.00
INMD balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 3219000.00
INMD balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 3219000.00
INMD balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 12093000.00
INMD balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 12093000.00
INMD balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 12093000.00
INMD balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 12093000.00
INMD balance_sheet (annual, 2025-12-31) — Current Liabilities: 70744000.00
INMD balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 70744000.00
INMD balance_sheet (annual, 2025-12-31) — Current Provisions: 931000.00
INMD balance_sheet (quarterly, 2025-12-31) — Current Provisions: 931000.00
INMD cash_flow (annual, 2025-12-31) — Deferred Income Tax: 2928000.00
INMD cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 864000.00
INMD cash_flow (annual, 2025-12-31) — Deferred Tax: 2928000.00
INMD cash_flow (quarterly, 2025-12-31) — Deferred Tax: 864000.00
INMD cash_flow (annual, 2025-12-31) — Depreciation: 695000.00
INMD cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 695000.00
INMD cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 174000.00
INMD cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 695000.00
INMD cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 174000.00
INMD income_statement (annual, 2025-12-31) — Diluted Average Shares: 65445000.00
INMD income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 64082000.00
INMD income_statement (annual, 2025-12-31) — Diluted EPS: 1.43
INMD income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.42
INMD income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 93831000.00
INMD income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 27025000.00
INMD income_statement (annual, 2025-12-31) — EBIT: 85387000.00
INMD income_statement (quarterly, 2025-12-31) — EBIT: 25991000.00
INMD income_statement (annual, 2025-12-31) — EBITDA: 86082000.00
INMD income_statement (quarterly, 2025-12-31) — EBITDA: 26165000.00
INMD cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 1984000.00
INMD cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 72000.00
INMD cash_flow (annual, 2025-12-31) — End Cash Position: 302543000.00
INMD cash_flow (quarterly, 2025-12-31) — End Cash Position: 302543000.00
INMD cash_flow (annual, 2025-12-31) — Financing Cash Flow: -126059000.00
INMD cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 137000.00
INMD balance_sheet (annual, 2025-12-31) — Finished Goods: 46863000.00
INMD balance_sheet (quarterly, 2025-12-31) — Finished Goods: 46863000.00
INMD cash_flow (annual, 2025-12-31) — Free Cash Flow: 84285000.00
INMD cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 22140000.00
INMD cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 15000.00
INMD cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 1000.00
INMD balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 69000.00
INMD balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 69000.00
INMD income_statement (annual, 2025-12-31) — General And Administrative Expense: 11686000.00
INMD income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 3393000.00
INMD balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 45875000.00
INMD balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 45875000.00
INMD balance_sheet (annual, 2025-12-31) — Gross PPE: 15753000.00
INMD balance_sheet (quarterly, 2025-12-31) — Gross PPE: 15753000.00
INMD income_statement (annual, 2025-12-31) — Gross Profit: 290970000.00
INMD income_statement (quarterly, 2025-12-31) — Gross Profit: 81300000.00
INMD cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 14867000.00
INMD balance_sheet (annual, 2025-12-31) — Income Tax Payable: 761000.00
INMD balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 761000.00
INMD income_statement (annual, 2025-12-31) — Interest Income: 24943000.00
INMD income_statement (annual, 2025-12-31) — Interest Income Non Operating: 24943000.00
INMD balance_sheet (annual, 2025-12-31) — Inventory: 74050000.00
INMD balance_sheet (quarterly, 2025-12-31) — Inventory: 74050000.00
INMD balance_sheet (annual, 2025-12-31) — Invested Capital: 683198000.00
INMD balance_sheet (quarterly, 2025-12-31) — Invested Capital: 683198000.00
INMD cash_flow (annual, 2025-12-31) — Investing Cash Flow: 186032000.00
INMD cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 27223000.00
INMD balance_sheet (annual, 2025-12-31) — Investments And Advances: 700000.00
INMD balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 700000.00
INMD balance_sheet (annual, 2025-12-31) — Investments In Other Ventures Under Equity Method: 700000.00
INMD balance_sheet (quarterly, 2025-12-31) — Investments In Other Ventures Under Equity Method: 700000.00
INMD balance_sheet (annual, 2025-12-31) — Leases: 1422000.00
INMD balance_sheet (quarterly, 2025-12-31) — Leases: 1422000.00
INMD balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 5008000.00
INMD balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 5008000.00
INMD balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 5008000.00
INMD balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 5008000.00
INMD balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 700000.00
INMD balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 700000.00
INMD balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 2252000.00
INMD balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 2252000.00
INMD cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -127444000.00
INMD cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
INMD income_statement (annual, 2025-12-31) — Net Income: 93831000.00
INMD income_statement (quarterly, 2025-12-31) — Net Income: 27025000.00
INMD income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 93831000.00
INMD income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 27025000.00
INMD income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 93831000.00
INMD income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 27025000.00
INMD income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 93831000.00